How self-monitoring and motivation fuel online weight loss success

Study reveals that successful weight loss in Chinese adults participating in an online group intervention correlates with high motivation, regular self-monitoring, and detailed progress logs, emphasizing the importance of adherence and motivation.

Exploring the current use and future of alternatives to traditional informed consent in acute stroke trials

The University of Cincinnati’s Yasmin Aziz, MD, and Joseph Broderick, MD, coauthored an editorial published Nov. 7 in the journal Neurology analyzing the current use

November 9, 2024

Merz wins $185m bid for bankrupt Acorda assets and increases US workforce by 50% – Pharmaceutical Technology

Fampyra used to see sales of over $500m in 2017, but sales weakened after generics entered the market. Image credit: Shutterstock / Elena Abrazhevich. Merz

July 11, 2024

Optimi Health & ATMA Receive No Objection Letter from Health Canada for Phase 2 Clinical Trial | Psychedelic Invest

Vancouver, British Columbia–(Newsfile Corp. – August 28, 2024) – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company“), a GMP-compliant, Health

August 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.